Measuring the value of life: exploring a new method for deriving the monetary value of a QALY

Tilling, C and Krol, M and Tsuchiya, A and Brazier, J and van Exel, J and Brouwer, W (2009): Measuring the value of life: exploring a new method for deriving the monetary value of a QALY.

Abstract

In this paper we present an alternative approach to estimating the monetary value of a QALY (MVQ), which is based upon a time trade off (TTO) exercise of income with health held constant at perfect health. We present the methods and theory underlying this experimental approach and some results from an online feasibility study in the Netherlands.

• Item Type: MPRA Paper
• Language: English
• Keywords: QALYs; time trade off; quality of life valuation
• Subjects: I - Health, Education, and Welfare > I3 - Welfare, Well-Being, and Poverty > I31 - General Welfare, Well-Being; I - Health, Education, and Welfare > I1 - Health > I19 - Other

References

Abelson P (2003). The value of life and health for public policy. The Economic Record 79:S2-S13.

Bleichrodt H, Quiggin J (1999). Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? Journal of Health Economics 18(6):681-708.

Bohm P (1984). Revealing demand for an actual public good. Journal of Public Economics 24:135-51.

Brubaker ER (1984). Demand disclosures and conditions on exclusion: An experiment. The Economic Journal 94:536-53.

Chestnut KL, Lambert W, Rowe R (1996). Measuring heart patients’ willingness to pay for changes in angina symptoms. Medical Decision Making 16(1):65-77.

Dalmau-Matarrodona E (2001). Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Health Economics 10:101-18.

Dolan P, Edlin R (2002). Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? Journal of Health Economics 21:827-43.

Donaldson C (1999). Valuing the benefits of publicly-provided health care: does "ability to pay" preclude the use of "willingness to pay"? Social Science and Medicine 49:551-63.

Frew EJ (2003). Willingness to pay for colorectal cancer screening: a comparison of elicitation formats. PhD Thesis. University of Nottingham.

Gold MR, Siegel JE, Russell LB, Weinstein MC (1996). Cost-effectiveness in health and medicine. Oxford: Oxford University Press.

Gyrd-Hansen D (2003). Willingness to pay for a QALY. Health Economics 112:1049-60.

Hackl F, Pruckner GJ (2005). Warm glow, free-riding and vehicle neutrality in a health-related contingent valuation study. Health Economics 14(3):293-306.

Hayes K, Lockwood M, Anderson G (1992). Estimating the benefits of water quality improvements in the Upper Narragansett Bay. Marine Resource Economics 7:75-85.

Hicks JR (1939). Value and capital: An enquiry into some fundamental principles of economic theory. Oxford: Clarendon Press.

Hirth RA, Chernew ME, Miller E, Fendrick M, Weisser WG (2000). Willingness to pay for a quality adjusted life year: in search of a standard. Medical Decision Making 20:332-42.

Johannesson M, Johansson P-O (1997). Quality of life and the WTP for an increase in life expectancy at an advanced age. Journal of Public Economics 65:219-28.

Johannesson M, Meltzer D (1998). Some reflections on cost-effectiveness analysis. Health Economics 7(1):1-7.

Johnson FR, Desvousges WH, Ruby M, Stieb D, De Civita P (1998). Eliciting stated health preferences: an application to willingness to pay for longevity. Medical Decision Making 18:S57-S67.

Jones-Lee MW, Loomes G, Phillips PR (1995). Valuing the prevention of non-fatal road injuries: Contingent valuation vs standard gambles. Oxford Economic Papers 47:676-95.

Kahneman D, Tversky A (1979). Prospect theory: an analysis of decision under risk. Econometrica 47(2):263-91.

Kartmann B, Nils-Olov S, Magnus J (1996). Valuation of health changes with the contingent valuation method: a test of scope and question order effects. Health Economics 5:531-41.

Kartman B, Andersson F, Johannesson M (1996). Willingness to pay for reduction in angina pectoris attacks. Medical Decision Making 16:248-53.

King JT jr, Tsevat J, Lave JR, Roberts MS (2005). Willingness to pay for a quality adjusted life year implications for societal health care resource allocation. Medical Decision Making 25(6):667-77.

Layard R, Mayraz G, Nickell S (2008). The marginal utility of income. Journal of Public Economics 92(8):1846–57.

Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M (1999). Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. British Journal of Dermatology 141:1067-75.

Mason H, Jones-Lee M, Donaldson C (2009). Modelling the monetary value of a QALY: a new approach based on UK data. Health Economics 18:933-50.

Milon WJ (1989). Contingent valuation experiments for strategic behavior. Journal of Environmental Economics and Management 17:293-308.

National Institute for Clinical Excellence (2008). NICE guide to the methods of technology appraisal. NICE, UK.

O’Brien B, Drummond MF (1994). Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5:389-98.

O’Brien BJ, Gafni A (1996). When do the “dollars” make sense? Toward a conceptual framework for contingent valuation studies in health care. Medical Decision Making 16:288-99.

Olsen JA, Donaldson C, Pereira J (2004). The insensitivity of "willingness-to-pay" to the size of the good: New evidence for health care. Journal of Economic Psychology 25:445-60.

Prades JLP, Loomes G, Brey R (2009). Trying to estimate a monetary value for the QALY. Journal of Health Economics 28:553-62.

Rawlins MD, Culyer AJ (2004). National Institute for Clinical Excellence and its value judgements. BMJ 329:224-7.

Smith R, Richardson J (2005). Can we estimate the "social" value of a QALY? Four core issues to resolve. Health Policy 74:77-84.

Smith VK, Desvouges WH (1987). An empirical analysis of the economic value of risk changes. Journal of Political Economy 95(1):89-114.

Stewart JM, O’Shea E, Donaldson C, Shackley P (2002). Do ordering effects matter in willingness-to-pay studies of health care? Journal of Health Economics 21:585-99.

Tilling C, Krol M, Tsuchiya A, Brazier J, Van Exel J, Brouwer WBF (2009). The impact of losses in income due to ill health: Does the EQ-5D reflect lost earnings? Health Economics and Decision Science Discussion Paper Series, School of Health and Related Research, University of Sheffield.

Van Nooten FE, Koolman X, Brouwer WBF (2009). Thirty down, ten to go? Health Economics, in press.

Weinstein M, Stason W (1977). Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296:716-21.